2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 25962959 | Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer. | 2015 Jun 20 | 1 |
| 2 | 23527225 | The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling. | 2013 | 1 |